1. No category

Draft 3/4/2015
GAP 2015 Conference – April 14 – 16, 2015
Tuesday, Wednesday, Thursday
The University of Texas MD Anderson Cancer Center
th
R. Lee Clark Building, 11 Floor
Hickey Auditorium and Conference Rooms 1- 8, R11.1100
1515 Holcombe Blvd.
Houston, Texas, 77030
“Eliminating Cancer through Global Partnerships”
Tuesday, April 14, 2015
7:30 – 8:30 am
Registration and Breakfast
8:30 - 8:40 am
Welcome Remarks (Hickey Auditorium)
Ronald DePinho, MD, President
MOON SHOT UPDATES
8:40 – 9:00 am
Women’s cancers: triple negative breast and ovarian
Gordon Mills, MD, PhD, Chair and Professor, Systems Biology
Mien-Chie Hung, PhD, Chair and Professor, Molecular and Cellular Oncology
Anil Sood, MD, Professor, Gynecologic Oncology and Reproductive Medicine
9:00 – 9:20 am
Chronic lymphocytic leukemia
Michael Keating, MD, Professor, Leukemia
William Plunkett, PhD, Professor, Experimental Therapeutics
9:20 – 9:40 am
Lung cancer
John Heymach, MD, PhD, Chair and Professor, Thoracic/Head and Neck Medical
Oncology
Stephen Swisher, MD, Chair and Professor, Thoracic and Cardiovascular Surgery
9:40 – 10:00 am
Melanoma
Jeffrey Gershenwald, MD, Professor, Surgical Oncology
Michael Davies, MD, PhD, Associate Professor, Melanoma Medical Oncology
10:00 – 10:20 am
Prostate cancer
Christopher Logothetis, MD, Chair and Professor, Genitourinary Medical
Oncology
Timothy Thompson, PhD, Professor, Genitourinary Medical Oncology – Research
10:20 – 10:40 am
Acute myeloid leukemia and myelodysplastic syndrome
Guillermo Garcia-Manero, MD, Professor, Leukemia
Hagop Kantarjian, MD, Chair and Professor, Leukemia
10:40 – 11:00 am
NEWLY PROPOSED MOON SHOTS
Giulio Draetta, MD, PhD, Professor, Molecular and Cellular Oncology
Andrew Futreal, PhD, Professor, Genomic Medicine
11:00 – 11:30 am
Coffee Break
GAP 2015 Conference
Page 1 of 20
Draft 3/4/2015
-DIVISION HIGHLIGHTSMarshall E. Hicks, MD, Professor and Division Head, Diagnostic Imaging, MD
Anderson
Stephen Hahn, MD, Professor and Division Head, Radiation Oncology, MD
Anderson
Anesthesiology & Critical Care
11:30 – 11:40 am
Enhanced Recovery after Cancer Surgery
Thomas Aloia, MD, Associate Professor, Surgical Oncology
Vijaya Gottumukkala, MD, Professor, Anesthesiology & PeriOperative Medicine
Breast Imaging
11:40 – 11:50 am
Molecular Breast Imaging
Beatriz E. Adrada, MD, Associate Professor, Diagnostic Radiology
11:50 – 12:00 pm
Optoacoustic Imaging
Basak E. Dogan, MD, Associate Professor, Diagnostic Radiology
Mohammed Eghtedari, MD, PhD, Assistant Professor, Diagnostic Radiology
12:00 – 12:10 pm
Advanced Imaging of Intrathoracic Malignancies: A Multidisciplinary
Approach
Brett Carter, MD, Associate Professor, Diagnostic Radiology
Cancer Prevention and Population Sciences
12:10 – 12:20 pm
The Changing Burden of Hepatitis C Virus infection in the United States:
Model Based Predictions
Jagpreet Chhatwal, PhD, Assistant Professor, Health Services Research
12:20 – 12:30 pm
A Unified Test of Linkage Analysis and Rare-Variant Association for Analysis of
Pedigree Sequence Data
Chad Huff, PhD, Assistant Professor, Epidemiology
12:30 – 12:40 pm
Prequit fMRI responses to Pleasant Cues and Cigarette-Related Cues Predict
Smoking Cessation Outcomes
Paul Cinciripini, PhD, Professor, Behavioral Sciences
Francesco Versace, PhD, Assistant Professor, Behavioral Science
Cancer Systems Imaging
12:40 – 12:50 pm
Chemical Reaction-Induced Multi-molecular Polarization (CRIMP)
Pratip Bhattacharya, PhD, Associate Professor, Cancer Systems Imaging
1:00 – 2:00 pm
LUNCH AND PRESENTATION (Hickey Auditorium)
1:00 – 1:30 pm
Moving Induced Cyclin Degradation from the Bench into the Cancer Clinic
Ethan Dmitrovsky, MD
American Cancer Society Professor
Departments of Thoracic/Head and Neck Medical Oncology and Cancer Biology,
MD Anderson
1:30 – 2:00 pm
Albert Einstein Hospital, AC Camargo Cancer Hospital, Barretos Cancer Hospital
(Brazilian Sister Institutions) - GAP 2016 Presentation
GAP 2015 Conference
Page 2 of 20
Draft 3/4/2015
-DIVISION HIGHLIGHTS- (Continued)
Internal Medicine
2:00 – 2:10 pm
Onco-Cardiology: A New Frontier / the Role of Topoisomerase in the
Development of Anthracycline-Induced Cardiotoxicity
Edward Yeh, MD, Professor and Chair, Cardiology
2:10 – 2:20 pm
Prevention of Pneumonia in Oncology Patients by Targeting Toll-like
Receptors
Burton F. Dickey, MD, Chair Pulmonary Medicine
Scott Evans, MD, Associate Professor, Pulmonary Medicine
2:20 – 2:30 pm
Advances in the Management of Metastatic Thyroid Cancer – A Paradigm
Shift
Steven I. Sherman, MD, Professor and Chair, Endocrine Neoplasia and HD
Pediatrics
2:30 – 2:40 pm
Adoptive Immunotherapy with Ex Vivo Expanded NK Cells for Leukemia, Solid
Tumors, and Brain Tumors
Dean A. Lee, MD, PhD, Associate Professor, Pediatrics – Patient Care
2:40 – 2:50 pm
Developing New Therapeutic Agents for Pediatric Cancer
Cindy L. Schwartz, MD, MPH, Deputy Head, Professor, Pediatrics – Patient Care
2:50 – 3:00 pm
Delivery of Chemotherapy into the Fourth Ventricle of the Brain: A Novel
Therapeutic Approach for Malignant Pediatric Brain Tumors
David Sandberg, MD, Clinical Specialist, Neurosurgery
Radiation Oncology
3:00 – 3:10 pm
Proton Therapy
Steven J, Frank, MD, Associate Professor, Radiation Oncology
3:10 – 3:20 pm
MRI Directed Radiation Therapy
Clifton Fuller, MD, Assistant Professor, Radiation Oncology
3:20 – 3:30 pm
Stereotactic Radiation (SBRT)
Joe Y. Chang, MD, PhD, Professor, Radiation Oncology
Surgery
3:30 – 3:40 pm
Minimally Invasive and New Technology on Oncologic Surgery (MINTOS)
Surena Matin, MD, Professor, Urology
George Chang, MD, Associate Professor, Surgical Oncology
3:40 – 3:50 pm
Sinonasal and Skull Base Surgery: Progress, Challenges, and Future Directions
Ehab Hanna, MD, Professor, Head and Neck Surgery
3:50 – 4:20 pm
Coffee Break
GAP 2015 Conference
Page 3 of 20
Draft 3/4/2015
SESSIONS (90 minutes)
4:20 – 5:50 pm
Session/Workshop 1 - Breast Cancer
Debasish Tripathy, MD, Professor & Chair, Breast Medical Oncology, MD
Anderson
Henry Gomez Moreno, MD, Medical Oncology, INEN (Lima, Peru)
Rodolfo Gomez, MD, Medical Oncology, IDC Las Americas (Medellin, Colombia)
4:20-4:30 pm
Prediction of recurrence risk in breast cancer patients using an autophagyrelated protein expression-based model
Lei Wang, MD, Doctoral Student, Fudan University Cancer Hospital (Shanghai,
China)
4:30-4:40 pm
Effect of screening mammography on breast-cancer survival in Brazilian
women
Edmundo Carvalho Mauad, MD, PhD, Director, Cancer Prevention, Barretos
Cancer Hospital (Barretos, Brazil)
4:40-4:50 pm
Screening for genomic rearrangements in BRCA1 and BRCA2 genes in 16
Peruvian breast cancer families by Multiplex Ligation-dependent Probe
Amplification (MLPA)
Henry Gomez, MD, Medical Oncology, Oncosalud-Auna (Lima, Peru)
4:50-5:00 pm
Acyl-CoA synthetase 4 a novel target for hormonal resistance breast cancer.
Ernesto Podesta, MD, Medical Oncology, CEMIC (Buenos Aires, Argentina)
5:00-5:10 pm
Targeting of miRNA networks for prevention of basal like breast cancers
Anjana Bhardwaj, PhD, Assistant Professor, Surgical Oncology, MD Anderson
5:10-5:20 pm
Overexpression of histone demethylase KDM4A leads an epigenetic silencing
of tumor suppressor gene CHD5 in a breast cancer model.
Ernesto Soto-Reyes, MD, Associate Professor, Instituto Nacional de
Cancerologia-InCAN ( Mexico City, Mexico)
5:20-5:30 pm
Status of BRCA1 / 2 and the expression of low molecular weight isoform of
cyclin E in breast cancer triple negative depending on the race and survival
Sira Macalou, MD, Post-Doc/Fellow, Breast Medical Oncology, MD Anderson
5:30-5:40 pm
Navigation Programs´s Impact in a Colombian Breast Cancer Patients Cohort
Fernando Herazo-Maya, MD, Professor, Instituto de Cancerologia, Clinica Las
Americas IDC ( Medellin, Colombia)
4:20 -5:50 pm
Session/Workshop 2 - The Critical Role of Prospective Cohorts in
Advancement of Personalized Medicine
Xifeng Wu, MD, PhD, Professor & Chair, Epidemiology, MD Anderson
Mario Fernandez, MD, Urology, Clinica Alemana (Santiago, Chile)
4:20 – 4:25 pm
Introduction
Alejandro Mohar, MD, Professor, InCAN (Mexico City, Mexico)
4:25 – 4:40 pm
Prospective Cohorts Enabling Discovery and Development of Novel
Biomarkers, Risk Signatures and Prediction Models for Cancer Risk and
Outcomes
Xifeng Wu, MD, Professor & Chair, Epidemiology, MD Anderson
GAP 2015 Conference
Page 4 of 20
Draft 3/4/2015
4:40 – 4:55 pm
Association of genetic variants with the presence of Bladder Cancer in an
arsenic-exposed population
Mario Fernandez, MD, Assistant Professor, Urology, Clinica Alemana (Santiago,
Chile)
4:55 – 5:10 pm
Are patients’ clinical data important for skin cancer population screening via
teledermatology?
Edmundo Carvalho Mauad, MD, PhD, Chair of Prevention & Medical Director,
Barretos Cancer Hospital (Barretos, Brazil)
5:10 – 5:25 pm
Joint biobanks for easier access of common and uncommon cancer samples
and data
Menghong Sun, MD, Professor, Fudan University Cancer Hospital (Shanghai,
China)
5:25 – 5:40 pm
The Mexican American Mano A Mano Cohort
Hua Zhao, PhD, Associate Professor, Epidemiology, MD Anderson
4:20 – 5:50 pm
Session/Workshop 3 - Gastrointestinal Cancers
Robert Wolff, MD, Professor & Chair, Gastrointestinal Medical Oncology, MD
Anderson
Hyun Cheol Chung, MD, PhD, Professor, Medical Oncology, Yonsei Cancer
Center (Seoul, Korea)
Ingemar Ernberg, MD, PhD, Professor and Chair, KI Cancer Network, Karolinska
Institutet (Stockholm, Sweden)
4:20 – 4:30 pm
Comparison between an Immunochemical Faecal Occult Blood Test and a
Guaiac Based Faecal Occult Blood Test in detection of adenomas and
colorectal cancer
Samuel Aguiar Junior, MD PhD, Professor, Surgical Oncology, AC Camargo
Cancer Hospital (Sao Paulo, Brazil)
4:30 – 4:40 pm
Establishment of Patient-Derived Xenograft as a Para-Clinical Model System
in Gastric Cancer: Initial Experience from a Single Institute
Yoon Young Choi, MD, Post-Doc Fellow Yonsei University Medical Center
(Seoul, Korea)
4:40 – 4:50 pm
Performance of a Nomogram Individually Predicting Overall Survival after
Curative Resection with D2 Lymphadenectomy for Advanced Gastric Cancer
Patients in China
Wei Wang, MD, Assistant Professor, Sun Yat-sen University Cancer Center
(Guangzhou, China)
4:50 – 5:00 pm
Comparison of KRAS and PIK3CA gene status between primary tumours and
paired metastases in metastatic or recurrent Colorectal Cancer
Jieer, Ying, MD, Professor, Zhejiang Provincial Cancer Hospital
(Hangzhou, China)
5:00 – 5:10 pm
Analysis of pyknons expression in a Brazilian cohort of colorectal cancer
patients
Rui Manuel Reis, MD, PhD, Research Coordinator, Molecular Oncology Center,
Barretos Cancer Hospital (Barretos, Brazil)
GAP 2015 Conference
Page 5 of 20
Draft 3/4/2015
5:10 – 5:20 pm
PD-L1 Expression on Gastric cancer and Its Relationship with Clinicopathologic
factors
Miaozhen Qui, MD, Professor, Sun Yat-sen University Cancer Center
(Guangzhou, China)
5:20 – 5:30 pm
Activation of Nuclear PTEN by Inhibition of Notch Signaling Induces G2/M Cell
Cycle Arrest in Gastric Cancer
Kyung-Hee Chun, MD, Assistant Professor, Yonsei University Cancer Center
(Seoul, South Korea)
5:30 – 5:40 pm
Clinical relevance of circulating tumor DNA in plasma from pancreatic cancer
patients
Oddmund Nordgard, MD, Associate Professor, Stavanger University Hospital
(Stavanger, Norway)
5:40 – 5:50 pm
Clinical Significance of Interleukin-6 in Diagnosis of, Oral, Esophageal, Gall
Bladder and Lung carcinomas
Anjali Vinocha, MD, Assistant Professor, Delhi State Cancer Institute (New
Delhi, India)
4:20 – 5:50 pm
Session/Workshop 4 - Genomic Marker-guided Medicine Initiative – GEMINI
Project
John Heymach, MD, Professor & Chair, Thoracic Head & Neck/Medical
Oncology, MD Anderson
Ricardo Santos, MD, Thoracic Surgery, Albert Einstein Hospital (Sao Paulo,
Brazil)
Amir Onn, MD, Professor and Head, Pulmonary Institute, The Chaim Sheba
Medical Center (Tel Hashomer, Israel)
7:00 – 9:30 pm
Welcome Address and Reception
Ronald DePinho, MD, President,
The University of Texas MD Anderson Cancer Center
Hotel ZaZa – Phantom Ballroom
5701 Main Street, Houston, TX 77005
713-526-1991 telephone
Wednesday, April 15, 2015
7:30 – 8:30 am
Registration, Breakfast and Poster Session
PLENARY SESSION (Hickey Auditorium)
8:30 – 9:00 am
Transforming Cancer Care Delivery Through Cutting Edge Technology
Lynda Chin, MD, Professor and Chair, Genomic Medicine, MD Anderson
9:00 – 9:20 am
IBM – Cognitive Computing
9:20 – 9:40 am
PWC – Data Interchange
9:40 – 10:00 am
AT&T - Mobility
10:00 – 10:30 am
Q&A
10:30 – 11:00 am
Coffee Break
GAP 2015 Conference
Page 6 of 20
Draft 3/4/2015
11:00 – 12:30 pm
Session/Workshop 5 - Genitourinary Cancers
Christopher Logothetis, MD, Professor and Chair, Genitourinary Medical
Oncology, MD Anderson
Dingwei Ye, MD, PhD, Professor, VP, Urology Surgery, Fudan University
Shanghai Cancer Center (Shanghai, China)
Nicolas G. Zouain, MD, Asst. Professor, Radiation Oncology, American
University of Beirut Medical Center (Beirut, Lebanon)
11:00-11:15 am
Study of circulating exosomal microRNAs as new biomarkers for diagnosis of
renal cancer
An Zhao, MD, Post-Doc/Fellow, Zhejiang Provincial Cancer Hospital (Hangzhou,
China)
11:15-11:30 am
Development of a Preliminary Nomogram to Predict Progression of Bone Scan
for Castration Resistant Prostate Cancer
Guo-Wen Lin, MD, Post-Doc/Fellow, Fudan University Cancer Hospital
(Shanghai, China)
11:30-11:45 am
Development and validation of nomogram to estimate the risk of prostate
cancer in a Brazilian population
Edmundo Carvalho Mauad, MD, PhD, Director, Barretos Cancer Hospital
(Barretos, Brazil)
11:45-12:00 pm
Decreased incidence rate of acute toxicity with prostate-based image-guided
approach compared with boney structure-based approach in external-beam
radiotherapy of prostate cancer
Kiyonao Nakamura, MD, Doctoral Student, Kyoto University (Kyoto, Japan)
12:00-12:15 pm
12:15-12:30 pm
Clinical and Prognostic Features of Chromophobe Renal Cell Carcinoma
Zaida Morante, MD, Medical Oncology, National Cancer Center of Peru-INEN
(Lima, Peru)
11:00 – 12:30 pm
Session/Workshop 6 – Genomic Medicine
Andrew Futreal, PhD, Professor, Genomic Medicine
Maciej Wiznerowicz, MD, Greater Poland Cancer Center
Gideon Rechavi, MD, Head, Sheba Cancer Center, Sheba Medical Center (Tel
Hashomer, Israel)
11:10-11:15 am
Association between VEGFA Polymorphisms and Severe Acute Oral Mucositis
in Nasopharyngeal Carcinoma Patients
Huai Liu, ??, Hunan Provincial Cancer Hospital (???, China)
11:15-11:30 am
Applying TCGA data for cancer diagnostics and pathway analysis
Maciej Wiznerowicz, MD, Associate Professor, Polish Oncology Consortium
(Warsaw, Poland)
Prospective Study Of Molecular Markers In Patients With Advanced Lung
Adenocarcinoma: Updated results from GAP 2014
Gonzalo Recondo, MD, Medical Oncology, CEMIC (Buenos Aires, Argentina)
11:30-11:45 am
11:45-12:00 pm
GAP 2015 Conference
CARMA: Spectral Decomposition of Copy Number Profiles in Cancer
Anne-Lise Borresen-Dale, MD, Professor, Norwegian Cancer Consortium (Oslo,
Norway)
Page 7 of 20
Draft 3/4/2015
12:00-12:15 pm
Convergent de-differentiation during intra-patient evolution in therapy naïve
melanoma
Mark J. Shackleton, MD, Assistant Professor, Peter Mac Cancer Center
(Melbourne, Australia)
12:15-12:30 pm
Integrated analysis of single nucleotide variants and copy number variants
detected by whole exome sequencing in ovarian clear cell adenocarcinoma
Murakami Ryusuke, MD, Doctoral Student, Kyoto University (Kyoto, Japan)
11:00 – 12:30 pm
Session/Workshop 7 – GAP Network Partnerships for Global Health:
Promoting Global Health Through Education & Training
Ernest Hawk, MD, Division Head, Cancer Prevention & Population Sciences
Edward Trimble, MD, MPH, Director, Center for Global Health, National Cancer
Institute (NCI)
11:00-11:10 am
National Control Plan in Peru. “Hope Plan” (Plan Esperanza)
Tatiana Vidaurre-Rojas, MD, Director, National Cancer Institute of Peru-INEN
(Lima, Peru)
11:10-11:20 am
Population-based screening with careHPV in El Salvador
Mauricio Maza, MD, Chief Medical Officer, Basic Health International (San
Salvador, El Salvador)
11:20-11:30 am
MD Anderson’s Tobacco Treatment Program: A Multi-Layered Tobacco
Cessation Program for Cancer Patients
Paul Cinciripini, PhD, Chair, MD Anderson
11:30-11:40 am
Project COMET: Colombia and Mexico against Tobacco
Irene Tami-Maury, DrPH, Instructor, MD Anderson
11:40-11:50 am
Mobilizing a Co-ordinated Response for Cancer Prevention and Control in
South Africa
Vikash Sewram, MD, Director, African Cancer Institute, Stellenbosch University
(Capetown, South Africa)
11:50-12:00 pm
Project ECHO for cervical cancer screening and prevention in the Rio Grande
Valley along the Texas-Mexico border
Kathleen Schmeler, MD, Associate Professor, Gynecologic Oncology, MD
Anderson
12:00-12:10 pm
Pink Ribbon Red Ribbon: Advancing Women’s Cancer Care in Sub-Saharan
Africa
Doyin Oluwole, MD, Executive Director, Pink Ribbon Red Ribbon, George W
Bush Presidential Center (Dallas, Texas, USA)
12:30 – 1:30 pm
LUNCH AND PRESENTATION (Hickey Auditorium)
12:30 – 1:00 pm
????
Doug Pyle Sr, Director of International Affairs, ASCO (tbc)
1:00 – 1:30 pm
Strategy for Global Health at the National Cancer Institute (NCI)
Edward L. Trimble, MD, Director, Center for Global Health, National Cancer
Institute (NCI)
GAP 2015 Conference
Page 8 of 20
Draft 3/4/2015
1:30 – 3:00 pm
Session/Workshop 8 – Gynecologic Cancers
Larissa Meyer, MD, Assistant Professor, Gynecologic Oncology & Reproductive
Medicine, MD Anderson
Jose Humberto Fregnani, MD, PhD, Research Director, Barretos Cancer
Hospital (Barretos, Brazil)
Rene Pareja, MD, Gynecology, Instituto de Cancerologia, Clinica Las Americas
IDC (Medellin, Colombia)
1:30-1:37 pm
Assessing and monitoring cervical tumor in response to neoadjuvant
chemotherapy using quantitative analysis of contrast-enhanced
ultrasonography
Xiao-Qing Pei, MD, Associate Professor, Sun Yat-sen University Cancer Center
(Guangzhou, China)
1:37-1:44 pm
Salvage laparoscopic lymphadenectomy combined to chemotherapy and/or
radiation therapy for isolated para-aortic nodal recurrence of cervical cancer:
morbidity and outcomes of a case series
Audrey T. Tsunoda, MD, Professor, Barretos Cancer Hospital (Barretos, Brazil)
1:44-2:01 pm
Immediate radical trachelectomy versus neoadjuvant chemotherapy followed
by radical trachelectomy for patients with stage IB1 cervical cancer with
tumors 2 cm or larger: a literature review and analysis of oncological and
obstetrical outcomes
Rene Pareja, MD, Associate Professor, Instituto de Cancerologia, Clinica Las
Americas IDC (Medellin, Colombia)
Discussion
2:04-2:11 pm
Effective and feasible triage tests in Visual Inspection with Acetic Acid based
cervical cancer screening programs in low resource settings in India.
Sharmila A. Pimple, MD, Professor, Tata Memorial Hospital (Mumbai, India)
2:11-2:18 pm
Single Visit Approach to Cervical Cancer Prevention SAFE Project with Scaleup program: Lessons from Thailand
Khunying Kobchit, MD, Professor, Obstetrics and Gynecology, Chulalongkorn
University (Bangkok, Thailand)
Discussion
2:20-2:27 pm
Elevating Clinical and Research Standards: An Organizational Search for
Excellence by Structured Benchmarking
Henrik Lajer, MD, Chief, Gyne-Oncologist, Rigshospitalet, Copenhagen
University Hospital (Copenhagen, Denmark)
2:27-2:34 pm
Use of laparoscopic score to determine complete cytorreduction of advanced
ovarian cancer: Prospective study
Carlos E. Andrade, MD, Chair, ???Barretos Cancer Hospital (Barretos, Brazil)
2:34-2:41 pm
A comparative analysis in management of ovarian cancer between a major
tertiary cancer center and no oncological institutions in Medellín, Colombia
Gabriel J. Rendon, MD, Assistant Professor, Instituto de Cancerologia, Clinica
Las Americas IDC (Medellin, Colombia)
Discussion
GAP 2015 Conference
Page 9 of 20
Draft 3/4/2015
3:08-3:15 pm
Investigation on the quality of life and influential factors in Chinese women
with recurrent ovarian cancer
Zhu Yan Shao, MD, Post-Doc/Fellow, Zhejiang Provincial Cancer Hospital
(Hangzhou, China)
3:15-3:22 pm
Comprehensive Treatment and Prognostic Factors in Patients with
Carcinoma of the Cervical Stump
Lu Chen, MD, Professor, Zhejiang Provincial Cancer Hospital (Hangzhou, China)
1:30 – 3:00 pm
Session/Workshop 9 – Head & Neck Cancers
Ehab Y. Hanna, MD, Professor, Head & Neck Surgery, MD Anderson
Andre Lopes Carvalho, MD, PhD, Head & Neck Surgery, Director of Research
Institute, Barretos Cancer Hospital (Barretos Brazil)
Anil D’Cruz, MD, Head & Neck Surgery, Director, Tata Memorial Hospital
(Mumbai, India)
Establishment and Validation of Plasma Epstein-Barr Virus DNA-Based
prognostic Nomograms to Predict Recurrence of Primary Non-disseminated
Nasopharyngeal Carcinoma in the Endemic Area
Tang Lin-Quan, MD, Doctoral Student, Sun Yat-sen University Cancer Center
(Guangzhou, China)
Opportunistic screening for oral cancer using mobile and fixed units in Brazil
Edmundo Cravalho Mauad, MD, PhD, Director, Barretos Cancer Hospital
(Barretos, Brazil)
The prediction of radiosensitivity of nasopharyngeal carcinoma based on the
narrow band imaging endoscopy
Xiao-guang Ni, MD, Associate Professor, Chinese Academy of Medical Sciences
(Beijing, China)
In situ hybridization analysis of miR-146b-5p and miR-21 expression in thyroid
carcinoma and Prognostic implications
Zhenying Guo, MD, Zheijiang Cancer Hospital (Hangzhou, China)
Prospective Study of Combining the Plasma Load of Epstein-Barr Viral DNA
and the Tumor Response to Neoadjuvant Chemotherapy for Predicting
Clinical Outcome in Advanced-Stage Nasopharyngeal Carcinoma
Hai-Qiang Mai, MD, Professor, Sun Yat-sen University Cancer Center
(Guangzhou, China)
Design of an EGFR-targeting toxin for photochemical delivery. In vitro and in
vivo selectivity and efficacy in head and neck cancer
Anette Wayergang, MD, Post-Doc/Fellow, Norwegian Cancer Consortium (Oslo,
Norway)
Transcriptome Markers of Lymph Node Metastasis in Oral Squamous Cell
Carcinoma
Emmanuel Dias-Neto, PhD, Associate Professor, AC Camargo Cancer Hospital
(Sao Paulo, Brazil)
GAP 2015 Conference
Page 10 of 20
Draft 3/4/2015
1:30 – 3:00 pm
Session/Workshop 10 – Health Services Research
Sharon Giordano, MD, MPH, Professor & Chair, Health Services Research, MD
Anderson
Chun-Ru Chien, MD, China Medical University Hospital (Taiwan)
Niwat Boonyuan, MD, General, Director, Wattanosoth Cancer Hospital,
Bangkok Hospital (Bangkok, Thailand)
1:30-1:45 pm
Challenges in Implementing Lung Cancer Screening Programs in Primary Care
Settings
Robert J. Volk, PhD, Professor, Health Services Research, MD Anderson
1:45-2:00 pm
Cost-effectiveness Analysis of Low-dose CT Screening for Lung Cancer in China
Fei Liang, MD, Post-Doc/Fellow, Fudan University Cancer Hospital (Shanghai,
China)
Analysis of the expenses in breast cancer and lung cancer medical insurance
patients in Tianjin city in 2012-2013
Li Jun, Researcher, Tianjin Medical University Cancer Institute & Hospital
(Tianjin, China)
2:00-2:15 pm
2:15-2:30 pm
Cancer incidence and survival among Adolescent & Young Adults in Taiwan
Chun-Ru Chien, MD, Associate Professor, China Medical University Hospital
(Taichung, Taiwan)
2:30-2:45 pm
A program evaluation of best practice methods to assess integrated health
needs for breast cancer survivors
Katherine Gilmore, Project Consultant, Cancer Survivorship, MD Anderson
2:45-3:00 pm
A home-based health-promotion intervention to enhance quality of life
among Chinese cancer survivors: RENEW-C
Maris a C. Swartz, MD, Post-Doc/Fellow, University of Texas Medical Branch
(Galveston, Texas, USA)
1:30–3:00 pm
Session/Workshop 11 – Operative Consortia Groups
Oliver Bogler, PhD, Senior VP, Academic Affairs, VP, Global Academic Programs,
MD Anderson
Development of novel treatment for triple-negative breast cancer (TNBC) and
inflammatory breast cancer (IBC) through a collaboration between USA,
Japan, and Egypt
Naoto Ueno, MD, Professor, Breast Medical Oncology, MD Anderson
Hepatocellular Carcinoma International Biomarker Assessment Consortium
(HIBAC)
Ahmed O. Kaseb, MD, Associate Professor and Director, Hepatocellular
Carcinoma Program, Editor-in-Chief, Journal of Hepatocellular Carcinoma, MD
Anderson
Rare Pediatric Tumors Consortium
Cesar Nunez, MD, Professor, Pediatrics-Patient Care, MD Anderson
3:00–3:30 pm
GAP 2015 Conference
Coffee Break
Page 11 of 20
Draft 3/4/2015
3:30–5:00 pm
Session/Workshop 12 – Hemato-Oncology
Hagop Kantarjian, MD, Professor & Chair, Leukemia, MD Anderson
Nelson Hamerschlak, MD, PhD, Hematology-Oncology, Albert Einstein Hospital
(Brazil)
Alejandro Majlis, MD, Hemato-Oncology, Clinica Alemana (Santiago, Chile)
3:30-3:40 pm
Post-transplant cyclophosphamide for GvHD prophylaxis in matched sibling
donor allogeneic hematopoietic stem cell transplant
Surapol Issaragrisil, MD, FRCP, Professor, Director, Mahidol University, Siriraj
Hospital (Bangkok, Thailand)
3:40-3:50 pm
Adoptive therapy using chimeric antigen receptor (CAR) modified T cells or
expanded NK cells for the treatment of advanced hematologic malignancies
Partow Kebraiei, MD, Assistant Professor, Leukemia, MD Anderson
3:50-4:00 pm
Efficacy and tolerability of novel selective mitochondrial complex I inhibitor
Marina Konopleva, MD, Assistant Professor, Leukemia, MD Anderson
4:00-4:10 pm
Pharmacogenetics of busulfan: significant association between GSTA1
genotype, busulfan pharmacokinetics and short-term toxicity
Yngnar Floisand, MD, Attending Physician, Oslo University Hospital (Oslo,
Norway)
4:10-4:20 pm
Restrospective comparative analysis of clinical outcomes between elderly and
young patients in allogeneic hematopoietic stem cell transplantation
Eduardo Chapchap, MD, Hematology, Hospital Israelita Albert Einstein (Sao
Paulo, Brazil)
4:20-4:30 pm
Regulation of ibrutinib on microRNA-21 by inhibiting NF-kB and STAT3 in
multiple myeloma cells
Yafei Wang, MD, Associate Professor, Tianjin Medical University Cancer
Institute and Hospital (Tianjin, China)
4:30-4:40 pm
Clinical significance of protein expression of EZH2 and HDAC1, 2 in T-cell
lymphoma
Huilai Zhang, MD, Associate Professor, Tianjin Medical University Cancer Center
(Tianjin, China)
4:40-4:50 pm
Comparison of the effect of prophylactic lamivudine plus adefovir dipivoxil
versus lamivudine alone in preventing hepatitis B reactivation in HBsAgpositive lymphoma patients undergoing chemotherapy
Qingqing Cai, MD, Assistant Professor, Sun Yat-sen University Cancer Center
(Guoangzhou, China)
3:30–5:00 pm
Session/Workshop 13 – Hepatobiliary Oncology: Current Controversies and
Future Challenges
Thomas Aloia, MD, Associate Professor, Surgical Oncology, MD Anderson
Shailesh Shrikhande, MD, Professor, GI & Hepato-Biliary & Pancreatic Surgery,
Tata Memorial Hospital (Mumbai, India)
Minshan Chen, MD, Chair, Hepatobiliary Surgery, Sun Yat-Sen University Cancer
Center (Guangzhou, China)
GAP 2015 Conference
Page 12 of 20
Draft 3/4/2015
Oral Abstract Presentations (8 minutes presentation/2 minutes discussion)
3:30–3:40 pm
Surgical management of patients with hepatocellular carcinoma beyond BCLC
recommendation and survival analysis
Zhang Yefan, MD, Post-Doc/Fellow, Chinese Academy of Medical Sciences
(Beijing, China)
3:40–3:50 pm
Solid pseudopapillary neoplasms of the pancreas: a 19-year multicenter
experience in China
Pengfei Yu, MD, Assistant Professor, Zhejiang Provincial Cancer Hospital
(Hangzhou, China)
3:50–4:00 pm
Yonsei Criteria in Minimally Invasive Surgery for Left Sided Pancreatic Cancer
Chang Moo Kang, MD, Associate Professor, Yonsei University Medical Center
(Seoul, Korea)
4:00–4:15 pm
Discussion – Borderline/Resectable Pancreas Cancer
Shailesh Shrikhande, MD, Professor, GI, Hepato-Biliary & Pancreatic Surgery,
Tata Memorial Hospital (Mumbai, India)
4:15–4:30 pm
Discussion – Neoadjuvant and Adjuvant Therapy for Biliary Cancer
Milind Javle, MD, Professor, GI Medical Oncology, MD Anderson
4:30–5:00 pm
Hepatobiliary Interactive Case Presentations with Expert Panel
Thomas Aloia, MD, Associate Professor, Surgical Oncology, MD Anderson
3:30–5:00 pm
Session/Workshop 14 - Supportive and Palliative Care
David Hui, MD, Assistant Professor, Palliative Care Medicine, MD Anderson
Carlos Pavia, MD, Barretos Cancer Hospital (Barretos, Brazil)
Omar Shamieh, MD, King Hussein Cancer Center (Aman, Jordan)
3:30-3:50 pm
Multi-center Research in Supportive and Palliative Oncology: Challenges and
Opportunities
David Hui, MD, Assistant Professor, Palliative Care Medicine, MD Anderson
3:50–4:00 pm
Characteristics associated with End-of-Life decision making in terminal ill
patients
Xiaoli Gu, MD, Attending Physician, Fudan University Cancer Hospital
(Shanghai, China)
4:00-4:10 pm
Use of palliative chemo- and radiotherapy at the end of life in oncology
patients: prospective cohort study
Zhe Zhang, MD, Post-Doc/Fellow, Fudan University Cancer Hospital (Shanghai,
China)
4:10-4:20 pm
Place of death for patients treated at a tertiary cancer center in the Middle
East
Omar Shamieh, MD, MBA, Chairman, Palliative Care Department, King Hussein
Cancer Center (Aman, Jordan)
4:20-4:30 pm
Practicability and clinical impact of the web-based Edmonton Symptom
Assessment Scale (ESAS) application: Pilot study for the Internet-based
Computerized Patient Assessment System (iComPAsS) Project
Michael A. Mejia, MD, Training Officer, Benavides Cancer Institute, University
of Santo Tomas Hospital (Manila, Philippines)
GAP 2015 Conference
Page 13 of 20
Draft 3/4/2015
4:30-4:40 pm
Sleep Disturbance Contributes to CRF in Cancer Patients with Active Disease
Diwakar Balachandran, MD, Associate Professor, Palliative Care Medicine, MD
Anderson
4:40-4:50 pm
Preoperative embolization in surgical treatment of spinal metastases: a
randomized clinical trial of efficacy in decreasing intraoperative blood loss
Benny Dahl, MD, Professor, Rigshospitalet, Copenhagen University Hospital
(Copenhagen, Denmark)
4:50-5:00 pm
End-of-life care stress, Spiritual well-being and Burnout among Critical care
nurses
Kim Hyun Sook, RN, Yonsei University Medical Center (Seoul, Korea)
3:30–5:00 pm
Session/Workshop 15 – Immunotherapy
Cassian Yee, MD, PhD, Professor, Melanoma Medical Oncology
Rienk Offringa, MD, Immunotherapy, German Cancer Center – DKFZ
(Heidelberg, Germany)
Kalle Malmberg, MD, Radium Hospital (Olso, Norway)
5:00–6:00 pm
Buses return to hotel - Free evening
Thursday, April 16, 2015
7:30–8:30 am
Registration, Breakfast and Poster Session
PLENARY SESSION (Hickey Auditorium)
8:30–9:30 am
DNA Damage, Checkpoint Signaling and Therapeutic Opportunities
Helen Piwnica-Worms, PhD, Vice Provost, Science
9:30–11:00 am
Session/Workshop 16 – Institute of Personalized Cancer Therapy (IPCT)
John Mendelsohn, MD, Past President, Professor, Director, Khalifa Institute for
Personalized Cancer Therapy, MD Anderson
Gunnar Saeter, MD, PhD, Head, Institute for Cancer Research, Olso University
Hospital (Oslo, Norway)
Vladimir Lazar, MD, PhD, Founder and Chief Operating Officer of WIN
Consortium, Head, Integrated Biology Platform, Institute Gustave Roussy
(Villejuif, France)
9:30–9:45 am
Predictive value of early and late [18F]FDG-PET/CT uptake in elderly patients
with stageⅠ-Ⅱ non-small-cell lung cancer treated with stereotactic body
radiotherapy (SBRT)
Ningbo Liu, MD, Associate Professor, Tianjin Medical University Cancer Institute
& Hospital (Tianjin, China)
9:45–10:00 am
Enhanced expression of cohesin loading factor NIPBL confers poor prognosis
and chemotherapy resistance in non-small cell lung cancer
Weizhen Xu, MD, Associate Professor, Zhejiang Provincial Cancer Hospital
(Hangzhou, China)
10:00–10:15 am
Proline-rich tyrosine kinase 2 and its phosphorylated form pY881 are novel
prognostic markers for non-small cell lung cancer progression and patients’
overall survival
Bo-hua Kuang, MD, Doctoral Student, Sun Yat-sen University Cancer Center
(Guangzhou, China)
GAP 2015 Conference
Page 14 of 20
Draft 3/4/2015
10:15–10:30 am
MetAction n-of-1 trial: Actionable target identification for palliative systemic
therapy - paving the way for personalized cancer therapy in Norway
Anne-Lise Borresen-Dale, MD, Professor, Norwegian Cancer Consortium (Oslo,
Norway)
10:30–10:45 am
Two-staged approach in identifying therapeutic targets for patients with
advanced cancers
Russell R. Broaddus, MD, PhD, Professor, Pathology, MD Anderson
10:45–11:00 am
Overview of Personalized Cancer Therapy at MD Anderson
Gordon B. Mills, MD, PhD, Professor and Chair, Systems Biology, MD Anderson
9:30–11:00 am
Session/Workshop 17 – Viral Infections in Immunocompromised Cancer
Patients
Roy F. Chemaly, MD, MPH, Professor, Director, Infectious Diseases, MD
Anderson
Nelson Hamerschlak, MD, PhD, Chief, Hematology-oncology, Albert Einstein
Hospital (Sao Paulo, Brazil)
Surapol Issaragrisil, MD, FRCP, Professor, Director, Mahidol University, Siriraj
Hospital, (Bangkok, Thailand)
Javier Adachi, MD, Assoc. Professor, Infectious Diseases, MD Anderson
9:30–9:35 am
Welcome Remarks
9:35–10:05 am
Future Strategies for Prevention of CMV Infection after Hematopoietic Stem
Cell Transplantation
Roy Chemaly, MD, MPH, Professor, Infectious Diseases, MD Anderson
10:05–10:35 am
The Role of Serum Neutralizing Antibody in Protection against Respiratory
Syncytial Virus Disease
Pedro Piedra, MD, Professor, Molecular Virology and Microbiology, Pediatrics,
Baylor College of Medicine
10:35–10:45 am
Viral Respiratory Infections in a Brazilian Cancer Center
Ivan Franca, MD, Director, Infectious Diseases, AC Camargo Cancer Hospital
(Sao Paulo, Brazil)
10:45–10:55 am
Immune Monitoring with the T-spot-CMV assay of ALL-HCT recipients: A proof
of concept in the clinical setting
Dimpy Shah, PhD, Post-Doc/Fellow, Infectious Diseases, MD Anderson
10:55–11:00 am
Closing Remarks
9:30–11:00 am
Session/Workshop 18 – Integrative Oncology
Lorenzo Cohen, PhD, Professor, General Oncology – Research, MD Anderson
Paulo Tarso de Lima, MD, Albert Einstein Hospital (Sao Paulo, Brazil)
Rajesh K. Grover, MD, PGDHHM, Director and CEO, Delhi State Cancer
Institutes
9:30–11:00 am
Session Workshop 19 - Patient Centered Perioperative Care to Improve
Oncologic Outcomes
Vijaya Gottumukkala, MD, Professor, Anesthesiology & PeriOperative
Medicine, MD Anderson
Henrik Hehlet, MD, PhD, Surgical Pathophysiology, Rigshospitalet
(Copenhagen, Denmark)
GAP 2015 Conference
Page 15 of 20
Draft 3/4/2015
Bernhard Riedel, MB.ChB. FCA. MBA. PhD, Director, Department of
Anaesthetics, Peter MacCallum Cancer Centre (Melbourne, Australia)
Welcome and Introductions
9:30-9:35 am
Patient Centered Perioperative Care to Improve Oncologic Outcomes
Vijaya Gottumukkala, MD, Professor, Anesthesiology, MD Anderson
9:35-9:45 am
Why is Surgical Patient Still at Risk for Delayed Recovery?
Henrik Kehlet, MD, Surgical Pathophysiology, Righospitalet, Copenhagen
University (Copenhagen, Denmark)
9:45-9:55 am
Future of Perioperative Care of the Cancer Patient: How Can We Improve
Outcomes?
Berhard Riedel, MD, Director, Department of Anaesthetics, Peter MacCallum
Cancer Centre (Melbourne, Australia)
9:55-10:00 am
Discussion: Gottumukkala/Kehlet/Riedel
Team presentations from SIN on various ER efforts
10:00-10:05 am
Rigshospitalet Report on ER Initiative
Henrik Kehlet, MD, Surgical Pathophysiology, Righospitalet, Copenhagen
University (Copenhagen, Denmark)
10:05-10:10 am
Peter Mac Report on ER Initiative
Berhard Riedel, MD, Director, Department of Anaesthetics, Peter MacCallum
Cancer Centre (Melbourne, Australia)
10:10-10:15 am
MDA report on ER in Liver Surgery
Thomas Aloia, MD, Associate Professor, Surgical Oncology, MD Anderson
Vijaya Gottumukkala, MD, Associate Professor, Anesthesiology, MD Anderson
10:15-10:20 am
MDA Report on ER in Pulmonary & Esophageal surgery
Rice & Mena
10:20-10:25 am
MDA Report on ER Gynecologic Surgery
Larissa A. Meyer, MD, Assistant Professor, Gynecologic Oncology, MD
Anderson
Javier Lasala, MD, Assistant Professor, Anesthesiology & Perioperative Med.,
MD Anderson
10:25-10:30 am
MDA Report on ER in Genitourinary Surgery
Jay Bakul Shah, MD, Assistant Professor, Urology, MD Anderson
Juan P. Cata, MD, Assistant Professor, Anesthesiology, MD Anderson
10:30-10:45 am
Discussion: Speakers as panel members
10:45-10:55 am
Developing an integrated roadmap of project, team, and leadership actions
for accelerating implementation of enhanced recovery after surgery
programs; what works, where, and when?
John D. Calhoun, MD, Professor, MD Anderson
10:55-11:00 am
Discussion: Moderator – Berhard Riedel
11:00–11:30 am
Coffee Break
GAP 2015 Conference
Page 16 of 20
Draft 3/4/2015
11:30–1:00 pm
Session/Workshop 20 – Advances in Image-guided Therapy for Hepatocellular
Carcinoma
Rony Avritscher, MD, Associate Professor, Interventional Radiology, MD
Anderson
Donald Schomer, MD, Chair, Diagnostic Radiology, Banner MD Anderson
(Gilbert, Arizona)
Wentao Li, MD, PhD, Professor, Interventional Radiology, Fudan University
Shanghai Cancer Center (Shanghai, China)
11:30-11:45 am
HCC: Management Strategies in Advanced and Palliative Setting
Alda L. Tam, MD, Associate Professor, Interventional Radiology, MD Anderson
11:45-12:00 pm
Analysis of survival factors in patients with intermediate-advanced
hepatocellular carcinoma treated with transcatheter arterial
chemoembolization combined with sorafenib
Guoliang Shao, MD, Professor, Zhejiang Provincial Cancer Hospital (Hangzhou,
China)
12:00-12:15 pm
Unresectable HCC – Combination Therapies
Sanjay Gupta, MD, Professor, Interventional Radiology, MD Anderson
12:15-12:30 pm
In vitro three-dimensional morphometric analysis for hepatectomy of
centrally located hepatocellular carcinoma: A pilot study
Weigi Rong, MD, Professor, Chinese Academy of Medical Sciences, Peking
Union Medical College (Beijing, China)
12:30-12:45 pm
Perioperative Localization of Pulmonary Ground-Glass Opacity Lesions: Role
of Interventional Radiology
Almir VG Bitencourt, MD, Associate Professor, AC Camargo Cancer Hospital
(Sao Paulo, Brazil)
11:30–1:00 pm
Session/Workshop 21 – Oncologic Critical Care: Going Global
Kristen J. Price, MD, Professor and Chair, Critical Care, MD Anderson
Cristina Prata Amendola, MD, Head, Intensive Care Unit, Barretos Cancer
Hospital (Barretos, Brazil)
Chanchai Sittipunt, MD, Associate Professor, Pulmonary Critical Care Medicine,
Chulalongkom University (Bangkok, Thailand)
11:30-11:35 am
Welcome
Kristen Price, MD, Professor and Chair, Critical Care, MD Anderson
11-35-11:40 am
Global Oncological Critical Care Research Network
Joseph Nates, MD, Professor, ICU Medical Director & Deputy Chair, Critical
Care, MD Anderson
11:40-12:00 pm
Can Goal Directed Therapy Prevent Acute Kidney Injury in ICU?
Cristina Prata Amendola, MD, Chief of Service, Intensive Care, Barretos Cancer
Hospital (Barretos, Brazil)
12:00-12:20 pm
Diffuse Alveolar Hemorrhage in Patients with Stem Cell Transplant
Nisha Rathi, MD, Assistant Professor, Critical Care, MD Anderson
12:20-12:40 pm
Outcomes of Critically Ill Cancer Patients
Silvio Namendys-Silva, MD, Head, Critical Care Medicine, Instituto Nacional de
Cancerologia-InCAN (Mexico City, Mexico)
GAP 2015 Conference
Page 17 of 20
Draft 3/4/2015
12:40-1:00 pm
Smoke Cessation in ICU/CCU Patients
Chanchai Sittipunt, MD, Associate Professor, Pulmonary Critical Care Medicine,
Chulalongkom University (Bangkok, Thailand)
11:30–1:00 pm
Session/Workshop 22 – Sarcoma: Moving Towards Target/Pathway Driver
Therapy for Bone and Soft Tissue Sarcomas
Shreyaskumar Patel, MD, Professor, Sarcoma Medical Oncology
Piotr Rutkowski, MD, PhD, Head, Soft Tissue/Bone Sarcoma & Melanoma,
Maria Sklodowska-Curie (Warsaw, Poland)
Jilong Yang, MD, PhD, Bone and Soft Tissue Tumor, Tianjin Medical University
Cancer Hospital & Institute (Tianjin, China)
11:30–1:00 pm
Session/Workshop 23 – Sister Institution Network Fund (SINF)
Oliver Bogler, PhD, Sr. VP Academic Affairs, VP GAP
Otmar D. Weistler, MD, Director, German Cancer Center (Heidelberg, Germany)
Chao-Nan (Miles) Qian, MD, PhD, Professor and Vice President, Sun Yat-sen
University Cancer Center (Guangzhou, China)
11:30-11:38 am
CXCL17 suppresses migration of breast cancer cells due to EMT inhibition
Ya-jie Guo, MD, Professor, China Medical University Hospital, ???
11:38-11:46 am
Proteomic response in breast cancer treated with neoadjuvant chemotherapy
with and without bevacizumab: Reverse phase protein array (RPPA) results
from NeoAva - a randomized phase II study
Mads H. Haugen, PhD, Post-Doc/Fellow, Institute for Cancer Research, Oslo
University Hospital, Norwegian Cancer Consortium (Oslo, Norway)
11:46-11:52 am
Variation of Tumor Infiltrating Lymphocytes during Neoadjuvance in TripleNegative Breast Cancer
Carlos A. Casteneda, MD, ????, National Cancer Institute of Peru-INEN (Lima,
Peru)
11:52-12:00 pm
“VISA” systems targeting to breast cancer and breast cancer stem cells
Xiaoming Xie, MD, Sun Yat-sen University Cancer Center (Guangzhou, China)
12:00-12:08 pm
Integration of single-cell omics with spatially resolved assays to assess intratumor heterogeneity in locally advanced breast cancers treated with
neoadjuvant chemotherapy
Nicola Crosetto, MD, Asst. Professor, Medical Biophysics and Biochemistry,
Karolinska Institutet (Stockholm, Sweden)
12:08-12:16 pm
Drug repositioning for pharmacological manipulation of p53 family members
in p53 mutant and deficient lung tumors
Joanna Zawacka-Pankau, PhD, Asst. Professor, Microbiology, Tumor and Cell
Biology, Karolinska Institutet (Stockholm, Sweden)
12:16-12-24 pm
Genome-wide analysis of copy number aberrations (CNA) in renal cell
carcinomas
Rui Manuel Reis, MD, PhD, Research Coordinator, Molecular Oncology Center,
Barretos Cancer Hospital (Barretos, Brazil)
12:24-12:32 pm
Status report of application and development of mdaccAutoPlan system in
Tianjin Medical University Cancer Institute and Hospital
Shengpeng Jiang, MD, ????? Tianjin Medical University Cancer Institute and
Hospital (Tianjin, China)
GAP 2015 Conference
Page 18 of 20
Draft 3/4/2015
12:32-12:40 pm
Social and cultural context of betel quid consumption and its potential health
consequences
Ellen R. Gritz, PhD, Professor, Behavioral Science, MD Anderson
12:40-12:48 pm
Evaluation of a Smoking Prevention Program Internationally
Alex Prokorov, MD, PhD, Professor, Behavioral Science, MD Anderson
1:00–2:00 pm
Lunch
2:00–3:30 pm
Session/Workshop 24 – Theranostics: Combining Imaging and Therapy for
Cancer Patients
Homer Macapinlac, MD, Professor & Chair, Nuclear Medicine, MD Anderson
Andreas Kjaer, MD, PhD, MBA, Professor & Chief Physician, Nuclear Medicine &
PET, Rigshospitalet (Copenhagen, Denmark)
Eduardo Lima, MD, PhD, Head, Nuclear Medicine, AC Camargo Cancer Hospital
(Sao Paulo, Brazil)
2:00-2:18 pm
64Cu-DOTATATE PET for Neuroendocrine Tumors: a Prospective Head-toHead Comparison with 111In-DTPA-octreotide in 112 Patients
Annika Loft, MD, Chief Physician, Rigshospitalet, Copenhagen University
Hospital (Copenhagen, Denmark)
2:18-2:36 pm
The 3-D Voxel-Based Dosimetry and Dose Planning in Peptide Receptor
Radionuclide Therapy Based on 4-D SPECT/CT Acquisition
Kalevi Kairemo, MD, Professor, Docrates Cancer Center (Helsinki, Finland)
2:36-2:54 pm
uPAR PET/CT imaging in prostate cancer: a first-in-humans study
Andreas Kjaer, MD, Professor, Rigshospitalet, Copenhagen University Hospital
(Copenhagen, Denmark)
2:54-3:12 pm
Skeletal Tumor Burden on Baseline 18F-Flouride PET/CT Predicts Overall
Survival After Radium-223
Elba C. Etchebehere, MD, Assistant Professor, MD Anderson
3:12-3:30 pm
State of the daily use of the theranostic concept at AC Camargo Cancer Center
Eduardo N. P. Lima, MD, Professor, AC Camargo Cancer Hospital (Sao Paulo,
Brazil)
2:00–3:30 pm
Session/Workshop 25 – Training the Next Generation of Outstanding
Clinicians: Innovations in Oncology Education
Diane Bodurka, MD, Professor, Gynecologic Oncology & Reproductive
Medicine, VP, Medical Education, MD Anderson
Vikash Sewram, MD, Director, African Cancer Institute, Stellenbosch University
(Capetown, South Africa)
Xishan Hao, MD, PhD, President and Professor of Surgical Oncology, Tianjin
Medical University Cancer Institute (Tianjin, China)
2:00-2:15 pm
Interprofessional Education – Developing a collaborative practice-ready
workforce
Maura Polansky, Program Director, MD Anderson
2:15-2:30 pm
The Development and Effects of Evidence based Vascular Access Port
Management Education Program for Oncology Nurses in South Korea
Juhye Lee, Oncology Nurse, Yonsei University Medical Center (Seoul, Korea)
GAP 2015 Conference
Page 19 of 20
Draft 3/4/2015
2:30-2:45 pm
An Internal Medicine Cancer Diagnosis Clinic in a Comprehensive Cancer
Center
John T. Patlan, MD, Associate Professor, MD Anderson
2:45-3:00 pm
Simulation-based Education, Training and Assessment: Emerging Adult
Learning Strategies
Gregory H. Botz, MD, Associate Professor, MD Anderson
3:00-3:15 pm
CLER Time for a Change in the Educational Environment
Diane Bodurka, MD, Professsor, Gynecologic Oncology, Director, Medical
Education, MD Anderson
2:00–3:30 pm
Session/Workshop 26 – Tumor Microenvironment
Raghu Kalluri, MD, PhD, Professor & Chair, Cancer Biology, MD Anderson
Arne Ostman, MD, Professor, Oncology-Pathology, Karolinska Institutet
(Stockholm, Sweden)
Sonia A. Melo, PhD, IPATIMUP (Porto, Portugal)
2:00–2:15 pm
Marker-defined perivascular cells predict prognosis and response to
treatment
Arne Ostman, MD, Professor, Oncology-Pathology, Karolinska Institutet
(Stockholm, Sweden)
2:15–2:30 pm
Targeting extracellular vesicles/exosomes secretion in cancer treatment
Vilma R. Martins, PhD, Chair and Research Director, AC Camargo Cancer
Hospital (Sao Paulo, Brazil)
2:30–2:45 pm
Stromal cells impair response to anti-BRAF therapy by activating the mTOR
pathway and promoting the invasive phenotype in malignant melanoma
Lina Prasmickaite, PhD, Post-Doc/Fellow, Oslo University Hospital, The
Norwegian Radium Hospital (Oslo, Norway)
2:45–3:00 pm
The Function of Tumor Microenvironment in Cancer Progression and
Metastasis
Raghu Kalluri, PhD, Professor and Chair, Cancer Biology, MD Anderson
3:00–3:15 pm
Interleukin-22 is Required for Promotion of K-ras Mutant Lung Cancer
Nasim Khosravi, PhD, Post-Doc/Fellow, MD Anderson
3:30 pm
Conference Ends/Return to Hotel
GAP 2015 Conference
Page 20 of 20